Journal
JOURNAL OF PHARMACOLOGICAL SCIENCES
Volume 109, Issue 2, Pages 174-178Publisher
JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1254/jphs.08R29FM
Keywords
glycogen synthase kinase-3 beta (GSK-3 beta); memory reconsolidation; aging; neurofibrillary tangle (NFT)
Categories
Ask authors/readers for more resources
Glycogen synthase kinase-3 beta (GSK-3 beta) is a constitutively active kinase. Since its activation results in neurofibrillary tangle (NFT) deposits in aged and Alzheimer's disease (AD) brains, GSK-3 beta may be inhibited under normal conditions but activated under pathological conditions. Given its link to NFT formation, we sought to determine whether GSK-3 beta exists in the brain as a pathological time bomb that promotes disease development. To address this hypothesis, we analyzed GSK-3 beta heterozygote (GSK+/-) mice, which express GSK-3 beta at 50% wild-type levels. When tested in the Morris water maze test, GSK+/- mice surprisingly exhibited retrograde amnesia. Further analysis indicated that GSK+/- mice had impaired memory reconsolidation but normal memory consolidation. Therefore, we concluded that GSK-3 beta activation is required for memory reconsolidation in the adult brain.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available